Compare · ALXN vs CHMA

ALXN vs CHMA

Side-by-side comparison of Alexion Pharmaceuticals, Inc. (ALXN) and Chiasma, Inc. (CHMA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ALXN and CHMA operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
MetricALXNCHMA
Company
Alexion Pharmaceuticals, Inc.
Chiasma, Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Major Pharmaceuticals
Major Pharmaceuticals
Exchange
NASDAQ
NASDAQ
IPO
1996
2015
News (4w)
0
0
Recent ratings
0
0
CHMA

Chiasma, Inc.

Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.